Related Experiment Videos
Infrequent p53 gene mutations in medulloblastomas
R L Saylors1, D Sidransky, H S Friedman
1Department of Pediatrics, Washington University School of Medicine, St. Louis, Missouri 63110.
Abstract:
Cytogenetic and molecular studies of medulloblastomas have demonstrated frequent loss of sequences from the short arm of chromosome 17, possibly implicating loss or inactivation of the p53 tumor suppressor gene. We amplified exons 5 through 8 of the p53 gene by the polymerase chain reaction technique. These segments, which encompass the regions usually mutated in human tumors, were sequenced to search for p53 mutations in 12 medulloblastoma tumors, 8 xenografts, and 3 permanent cell lines. Mutation of the p53 gene was found in only 1 of 3 cell lines tested and in none of the xenografts or primary tumors studied. Our results suggest that p53 is mutated in an unusual way or that a second tumor suppressor gene on the short arm of chromosome 17 is involved in the pathogenesis of medulloblastoma.
Insights
Frequent chromosome 17 short arm losses in medulloblastoma may involve the p53 tumor suppressor gene. However, p53 mutations were rare in tumors and xenografts, suggesting alternative genetic mechanisms in medulloblastoma development.
Area of Science:
- Oncology
- Genetics
- Molecular Biology
Background:
- Medulloblastomas frequently exhibit chromosomal aberrations, specifically deletions on the short arm of chromosome 17.
- These genetic alterations suggest a potential role for tumor suppressor genes, such as p53, in medulloblastoma pathogenesis.
Purpose of the Study:
- To investigate the mutation status of the p53 tumor suppressor gene in medulloblastoma.
- To determine if p53 gene mutations correlate with the observed chromosome 17 short arm deletions in medulloblastoma.
Main Methods:
- Polymerase chain reaction (PCR) was used to amplify critical exons (5-8) of the p53 gene.
- DNA sequencing was performed on amplified p53 gene segments from medulloblastoma tumors, xenografts, and cell lines.
- Analysis focused on regions known to harbor common mutations in human cancers.
Main Results:
- P53 gene mutations were detected in only one of three medulloblastoma cell lines.
- No p53 mutations were identified in the twelve primary medulloblastoma tumors or eight xenografts studied.
- This indicates a low frequency of canonical p53 mutations in these medulloblastoma samples.
Conclusions:
- The findings suggest that p53 mutations are not a primary driver in most medulloblastomas.
- Alternative mechanisms, possibly involving a different tumor suppressor gene on chromosome 17 short arm, may contribute to medulloblastoma development.
- Further research is needed to elucidate the genetic landscape of medulloblastoma beyond p53.